Is Kobayashi Pharmaceutical Co., Ltd. (KBYPF) a Buy, Sell, or Hold?
OTC : KBYPF
Kobayashi Pharmaceutical Co., Ltd. — Institutional Ownership
$34.05 USD
$0 (0.0%)
- Volume
- 1.47K
- Average Volume
- 1.22K
- Market Capitalization
- $2.53B
- P/E Ratio
- 132.58
- Dividend Yield
- 1.92%
- Price Target
- Year High
- $37.43
- Year Low
- $34.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.04
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|
KBYPF Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5430.22 | 74.34M | $403.67B | $62.37B | $678.59M | $341.98B |
| 2024-12-31 | $5888.19 | 74.34M | $437.72B | $50.87B | $846M | $387.69B |
| 2023-12-31 | $7791.83 | 75.84M | $590.95B | $71.54B | $987M | $520.4B |
| 2022-12-31 | $7247.26 | 77.12M | $558.92B | $96.23B | $792M | $463.48B |
| 2021-12-31 | $9172.67 | 78.12M | $716.62B | $95.02B | $630M | $622.22B |
| 2020-12-31 | $6711.38 | 78.16M | $524.58B | $78.25B | $688M | $447.02B |
| 2019-12-31 | $7060.50 | 78.42M | $553.66B | $75.58B | $891M | $478.97B |
| 2018-12-31 | $4818.42 | 79.03M | $380.81B | $74.46B | $1.03B | $307.39B |
| 2017-12-31 | $4946.25 | 78.8M | $389.76B | $64.99B | $776M | $325.55B |
| 2016-12-31 | $5380.99 | 80.22M | $431.67B | $58.17B | $829M | $374.33B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5404.11 | 74.34M | $401.73B | $57.09B | $731.58M | $345.38B |
| 2025-12-31 | $5430.22 | 74.34M | $403.68B | $62.37B | $678.59M | $341.99B |
| 2025-09-30 | $5532.27 | 74.34M | $411.26B | $45.92B | $714.06M | $366.06B |
| 2025-06-30 | $5388.98 | 74.34M | $400.6B | $56.29B | $749M | $345.06B |
| 2025-03-31 | $5612.63 | 74.34M | $417.24B | $52.4B | $789M | $365.62B |
| 2024-12-31 | $5888.19 | 74.34M | $437.72B | $50.87B | $846M | $387.69B |
| 2024-09-30 | $4666.31 | 74.34M | $346.88B | $41.17B | $963M | $306.68B |
| 2024-06-30 | $5232.29 | 74.34M | $388.96B | $52.06B | $1.14B | $338.04B |
| 2024-03-31 | $4926.85 | 74.34M | $366.25B | $62.41B | $952M | $304.79B |
| 2023-12-31 | $7791.83 | 75.04M | $584.73B | $71.54B | $987M | $514.18B |
| 2023-09-30 | $8254.52 | 76.13M | $628.4B | $87.18B | $876M | $542.1B |
| 2023-06-30 | $7975.80 | 76.13M | $607.18B | $91.18B | $882M | $516.88B |